Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) shot up 0% on Tuesday following a dividend announcement from the company. The stock traded as high as $814.00 and last traded at $803.94.

Eli Lilly and Company (NYSE:LLY – Get Free Report) declared that its Board of Directors has approved a stock buyback program on Monday, December 9th, RTT News reports. The company plans to repurchase ...

In a recent SEC filing, it was revealed that Juan R Luciano, Board Member at Eli ... Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, ...